1. Home
  2. ABVX vs ZION Comparison

ABVX vs ZION Comparison

Compare ABVX & ZION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$119.20

Market Cap

9.7B

Sector

N/A

ML Signal

HOLD

Logo Zions Bancorporation N.A.

ZION

Zions Bancorporation N.A.

HOLD

Current Price

$60.93

Market Cap

9.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABVX
ZION
Founded
2013
1873
Country
France
United States
Employees
67
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ABVX
ZION
Price
$119.20
$60.93
Analyst Decision
Buy
Hold
Analyst Count
13
20
Target Price
$131.31
$62.40
AVG Volume (30 Days)
882.8K
1.5M
Earning Date
03-23-2026
04-20-2026
Dividend Yield
N/A
3.05%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$70.74
$8.45
Revenue Next Year
$3,694.18
$4.68
P/E Ratio
N/A
$10.32
Revenue Growth
N/A
N/A
52 Week Low
$5.20
$39.42
52 Week High
$148.83
$66.18

Technical Indicators

Market Signals
Indicator
ABVX
ZION
Relative Strength Index (RSI) 53.43 65.84
Support Level $105.48 $57.89
Resistance Level $130.20 $61.53
Average True Range (ATR) 5.76 1.39
MACD 0.89 0.73
Stochastic Oscillator 70.50 91.16

Price Performance

Historical Comparison
ABVX
ZION

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About ZION Zions Bancorporation N.A.

Zions Bancorp is a US regional bank with around $90 billion in total assets as of Sept. 30, 2025. Headquartered in Salt Lake City, Utah, Zions' branch network is in the Western and Southwestern United States and includes seven affiliate banks in these markets. The bank has a heavy focus on small and midsize commercial banking.

Share on Social Networks: